VALIANTLAB2026-04-012026-06-30VALIANTLAB2026-04-012026-06-30in-capmkt:OtherExpenses1Memberiso4217:INRxbrli:pureiso4217:INRxbrli:shares543998VALIANTLABNOTLISTEDINE0JWS01017Valiant Laboratories LimitedMain BoardEquity2026-04-012027-03-312026-08-102026-08-05INRLakhsQuarterlyFirst quarterSingle segmentManufacturing Chemicals2026-08-1016:30:002026-08-1018:00:00Not applicable2026-04-012026-06-30AuditedConsolidated115285100086030001161454000623495000116123000-6201900026005000106650002861100015666900089954900026190500002619050004319700076780005087500002110300000000211030000021103000021103000002110300000543125000103.893.89003.893.890001. The above results for the Quarter and year ended 30th June,2026 have been reviewed by the Audit Committee in their meeting held on 10th August,2026 and approved by the Board of Directors in their meeting held on 10th August,2026. <br /> <br /> 2 The Company is operating as a single segment company, engaged in manufacturing of chemicals business, and hence there is no separate reportable business segment. <br /> <br /> 3 The aforesaid Audited Financial results will be uploaded on the company's website www.valiantlabs.in and will also be available on the websites of BSE Limited i.e. www.bseindia.com / NSE Limited i.e www.nseindia.com <br /> <br /> 4 Figures for the previous period have been regrouped or rearranged wherever necessary.Other Expenses156669000The Company does not have separately identifiable operating segments. As such, segment reporting is not applicable for the purpose of financial results.